BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29353287)

  • 21. Associations of CXCL16, miR‑146a and miR‑146b in atherosclerotic apolipoprotein E‑knockout mice.
    Ma AJ; Zhu XY; Yang SN; Pan XD; Wang T; Wang Y; Xiao X; Liu SH
    Mol Med Rep; 2018 Sep; 18(3):2995-3002. PubMed ID: 30015963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
    Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
    J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer.
    Deng L; Chen N; Li Y; Zheng H; Lei Q
    Biochim Biophys Acta; 2010 Aug; 1806(1):42-9. PubMed ID: 20122997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of MUC1 by its novel activator 14-3-3ζ promotes tumor invasion and indicates poor prognosis in lung adenocarcinoma.
    Xue M; Tao W
    Oncol Rep; 2017 Nov; 38(5):2637-2646. PubMed ID: 28901525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
    Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
    Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of CCR7 promotes NF-κB-dependent apoptosis and suppresses epithelial-mesenchymal transition in non-small cell lung cancer.
    Zhang L; Xiao X; An H; Wang J; Ma Y; Qian YH
    Oncol Rep; 2017 May; 37(5):2913-2919. PubMed ID: 28339080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpressed D2 Dopamine Receptor Inhibits Non-Small Cell Lung Cancer Progression through Inhibiting NF-κB Signaling Pathway.
    Wu XY; Zhang CX; Deng LC; Xiao J; Yuan X; Zhang B; Hou ZB; Sheng ZH; Sun L; Jiang QC; Zhao W
    Cell Physiol Biochem; 2018; 48(6):2258-2272. PubMed ID: 30114693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Arsenic trioxide enhances TRAIL inducing human lung cancer cell line A549 cells apoptosis by down-regulate the expression of NF-kappaB].
    Wang JY; Zhao XQ; Wang CM; Mo BW; Jiang M; Chen F
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):834-8. PubMed ID: 23387208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polydatin suppresses proliferation and metastasis of non-small cell lung cancer cells by inhibiting NLRP3 inflammasome activation via NF-κB pathway.
    Zou J; Yang Y; Yang Y; Liu X
    Biomed Pharmacother; 2018 Dec; 108():130-136. PubMed ID: 30218857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 14-3-3ζ promotes lung cancer cell invasion by increasing the Snail protein expression through atypical protein kinase C (aPKC)/NF-κB signaling.
    Tong S; Xia T; Fan K; Jiang K; Zhai W; Li JS; Wang SH; Wang JJ
    Exp Cell Res; 2016 Oct; 348(1):1-9. PubMed ID: 27554601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z; Ma J; Li N; Sun N; Wang C
    Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.
    Hald SM; Kiselev Y; Al-Saad S; Richardsen E; Johannessen C; Eilertsen M; Kilvaer TK; Al-Shibli K; Andersen S; Busund LT; Bremnes RM; Donnem T
    BMC Cancer; 2015 May; 15():441. PubMed ID: 26021984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway.
    Yu M; Qi B; Xiaoxiang W; Xu J; Liu X
    Biomed Pharmacother; 2017 Jun; 90():677-685. PubMed ID: 28415048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
    Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
    Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells.
    He Z; Huang C; Lin G; Ye Y
    Oncol Rep; 2016 Apr; 35(4):1933-40. PubMed ID: 26847475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways.
    Chen Y; Li H; Li M; Niu S; Wang J; Shao H; Li T; Wang H
    J Ethnopharmacol; 2017 Mar; 200():165-173. PubMed ID: 28232127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BMP9 inhibits the growth and migration of lung adenocarcinoma A549 cells in a bone marrow stromal cell‑derived microenvironment through the MAPK/ERK and NF-κB pathways.
    Wang J; Weng Y; Zhang M; Li Y; Fan M; Guo Y; Sun Y; Li W; Shi Q
    Oncol Rep; 2016 Jul; 36(1):410-8. PubMed ID: 27177272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
    Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
    Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Huang L; Li F; Deng P; Hu C
    Oncol Res; 2016 Oct; 24(6):405-413. PubMed ID: 28281961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.